| Serena Etling, | |
|
13601 N Litchfield Rd Ste 124, Surprise, AZ 85379-4260 | |
| (623) 322-8250 | |
| Not Available |
| Full Name | Serena Etling |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 13601 N Litchfield Rd Ste 124, Surprise, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083369748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Serena Etling, 15508 W Bell Rd Ste 101-261, Surprise, AZ 85374-2432 Ph: () - | Serena Etling, 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379-4260 Ph: (623) 322-8250 |
News Archive
Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmerica, Inc. that was previously approved by Vivakor's Board of Directors.
Arena Pharmaceuticals has announced that it was issued U.S. patent number 6,902,902, entitled "Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders," by the U.S. Patent Office.
Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in the journal Breast Cancer Research reveals that qualitative studies on the recurrence of breast cancer in breast cancer survivors undergoing HRT are unreliable.
Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.
› Verified 3 days ago
Jennifer Stuart, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18510 N Parkview Pl, Surprise, AZ 85374 Phone: 623-546-8011 | |
Haley Cummings, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379 Phone: 800-376-3440 | |
Nicole Pruett, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15802 N Parkview Pl, Surprise, AZ 85374 Phone: 623-876-7000 | |
Brooke Cox, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379 Phone: 623-322-8250 | |
Elizabeth M Beane, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18343 W Saguaro Ln, Surprise, AZ 85388 Phone: 206-718-9671 | |
Michael Santiago, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 14815 W Bell Rd Ste 110, Surprise, AZ 85374 Phone: 623-777-1870 Fax: 623-777-1403 |